Company intelligence / Profile preview

Brazilian Clinical Research Institute

São Paulo, São Paulo, Brazil

Ownership: Private
Development stage: Other

Overview

BCRI has led and coordinated more than 50 clinical studies enrolling over 80,000 patients in areas such as cardiovascular disease, with internationally recognized academic partners and high-quality data generation. The partnership with Mount Sinai aims to advance prevention and treatment strategies for heart disease and stroke in Latin America.

Therapeutic areas: Internal MedicineCardiovascularNeurology
Modalities: Small moleculeBiologicDevice
Industry: Academic Hospital/University/Research

Partnerships

Icahn School of Medicine at Mount SinaiNational Institutes of Health (NIH)Local regulatory agenciesnational/international universities

Beyond the preview

Go deeper on Brazilian Clinical Research Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brazilian Clinical Research Institute.

Explore the full profile